Dr. Rosas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cambridge St
Houston, TX 77030Phone+1 713-798-2400Fax+1 713-798-2688
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1995 - 1998
Brooklyn Hospital CenterInternship, Internal Medicine, 1994 - 1995
National University of ColombiaClass of 1991
Certifications & Licensure
TX State Medical License 2019 - 2024
MA State Medical License 2008 - 2021
MD State Medical License 1997 - 2013
DC State Medical License 2004 - 2008
PA State Medical License 2005 - 2008
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 10 citationsSystemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi
Rheumatology. 2023-05-02 - 410 citationsSingle-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.Taylor Adams, Jonas C. Schupp, Sergio Poli, Ehab A. Ayaub, Nir Neumark
Science Advances. 2020-07-08 - 17 citationsFibroblasts positive for meflin have anti-fibrotic property in pulmonary fibrosis.Yoshio Nakahara, Naozumi Hashimoto, Koji Sakamoto, Atsushi Enomoto, Taylor Adams
The European Respiratory Journal. 2021-05-28
Journal Articles
- Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseaseJay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, The New England Journal of Medicine
Press Mentions
Digital Atlas Created for Chronic Lung DiseaseJuly 8th, 2020- All the Ways Doctors Are Treating Coronavirus Right NowJune 23rd, 2020
Devastating Disease of the Lung Is a New Research Gift’s FocusJuly 16th, 2018- Join now to see all
Grant Support
- Syndecan-2 And Clinical Progression Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2009–2012
- Syndecan-2 And Clinical Progression Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
